CBYL

KalVista Pharmaceuticals, Inc.CIK 1348911 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for CBYL PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for CBYL

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Maroney Marcee	VP, Clinical Affairs	8	$0	$0	2016-11-21
Renzi David	President & CEO	9	$0	$37.0K	2016-11-21
Basta Steven L	Director	5	$0	$0	2016-11-21
Saul David Joseph	Director	1	$0	$0	2016-02-01
McKune John	See Remarks	2	$0	$0	2016-01-04
Ramiya Premchandran	Vice President of Supply Chain	2	$0	$0	2016-01-04
Gravett David M.	VP, Research & Development	2	$0	$0	2016-01-04
Zadno Reza	Director	2	$0	$0	2015-08-03
Lewis Hayley	See Remarks	1	$0	$0	2015-08-03
Katkin Keith	Director	1	$0	$0	2015-08-03
Clapper David M	Director	1	$0	$0	2015-08-03
Unkart Edward W	Director	1	$0	$0	2015-08-03
Vivo Ventures VI, LLC	10% Owner	14	$5.06M	$0	2015-04-14
VIVO VENTURES VI AFFIILATES FUND, L.P.	10% Owner	14	$5.06M	$0	2015-04-14
InterWest Partners IX, LP	10% Owner	9	$4.05M	$0	2015-04-14
CHA ALBERT	Director	28	$10.13M	$0	2015-04-14
ACP IV, L.P.	10% Owner	9	$4.39M	$0	2015-04-14
NOHRA GUY P	Director	9	$4.39M	$0	2015-04-14

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Maroney Marcee	VP, Clinical Affairs	M Exercise deriv	2016-11-21	2016-11-22	1,339	—	$0	0	SEC↗
Maroney Marcee	VP, Clinical Affairs	M Exercise deriv	2016-11-21	2016-11-22	732	—	$0	0	SEC↗
Maroney Marcee	VP, Clinical Affairs	M Exercise deriv	2016-11-21	2016-11-22	2,592	—	$0	0	SEC↗
Basta Steven L	Director	M Exercise deriv	2016-11-21	2016-11-22	1,125	—	$0	0	SEC↗
Renzi David	President & CEO	M Exercise deriv	2016-11-21	2016-11-23	36,640	—	$0	0	SEC↗
Maroney Marcee	VP, Clinical Affairs	M Exercise	2016-11-21	2016-11-22	4,664	$7.84	$36.6K	4,664	SEC↗
Maroney Marcee	VP, Clinical Affairs	U Tender	2016-11-21	2016-11-22	409	$8.59	$3.5K	0	SEC↗
Maroney Marcee	VP, Clinical Affairs	F Tax w/h	2016-11-21	2016-11-22	4,255	$8.59	$36.6K	409	SEC↗
Basta Steven L	Director	F Tax w/h	2016-11-21	2016-11-22	1,026	$8.59	$8.8K	99	SEC↗
Basta Steven L	Director	U Tender	2016-11-21	2016-11-22	99	$8.59	$850	0	SEC↗
Basta Steven L	Director	M Exercise	2016-11-21	2016-11-22	1,125	$7.84	$8.8K	1,125	SEC↗
Renzi David	President & CEO	F Tax w/h	2016-11-21	2016-11-23	33,454	$8.59	$287.4K	3,186	SEC↗
Renzi David	President & CEO	U Tender	2016-11-21	2016-11-23	3,186	$8.59	$27.4K	0	SEC↗
Renzi David	President & CEO	M Exercise	2016-11-21	2016-11-23	36,640	$7.84	$287.3K	36,640	SEC↗
Saul David Joseph	Director	A Award deriv	2016-02-01	2016-02-02	56,000	—	$0	56,000	SEC↗
Maroney Marcee	VP, Clinical Affairs	A Award deriv	2016-01-04	2016-01-05	100,000	—	$0	100,000	SEC↗
Ramiya Premchandran	Vice President of Supply Cha	A Award deriv	2016-01-04	2016-01-05	60,586	—	$0	60,586	SEC↗
McKune John	See Remarks	A Award deriv	2016-01-04	2016-01-05	10,000	—	$0	10,000	SEC↗
Renzi David	President & CEO	A Award deriv	2016-01-04	2016-01-05	283,000	—	$0	283,000	SEC↗
Gravett David M.	VP, Research & Development	A Award deriv	2016-01-04	2016-01-05	100,000	—	$0	100,000	SEC↗
Renzi David	President & CEO	M Exercise deriv	2015-12-30	2015-12-31	10,000	—	$0	515,825	SEC↗
Renzi David	President & CEO	M Exercise	2015-12-30	2015-12-31	10,000	$0.56	$5.6K	10,000	SEC↗
Renzi David	President & CEO	S Sale	2015-12-30	2015-12-31	10,000	$3.70	$37.0K	0	SEC↗
McKune John	See Remarks	A Award deriv	2015-11-02	2015-11-04	50,000	—	$0	50,000	SEC↗
Unkart Edward W	Director	A Award deriv	2015-08-03	2015-08-05	29,000	—	$0	29,000	SEC↗
Zadno Reza	Director	A Award deriv	2015-08-03	2015-08-05	15,750	—	$0	15,750	SEC↗
Lewis Hayley	See Remarks	A Award deriv	2015-08-03	2015-08-05	33,181	—	$0	33,181	SEC↗
Ramiya Premchandran	Vice President of Supply Cha	A Award deriv	2015-08-03	2015-08-05	165,903	—	$0	165,903	SEC↗
Renzi David	President & CEO	A Award deriv	2015-08-03	2015-08-05	276,506	—	$0	276,506	SEC↗
Katkin Keith	Director	A Award deriv	2015-08-03	2015-08-05	29,000	—	$0	29,000	SEC↗
Basta Steven L	Director	A Award deriv	2015-08-03	2015-08-05	15,750	—	$0	15,750	SEC↗
Clapper David M	Director	A Award deriv	2015-08-03	2015-08-05	29,000	—	$0	29,000	SEC↗
Maroney Marcee	VP, Clinical Affairs	A Award deriv	2015-08-03	2015-08-05	60,831	—	$0	60,831	SEC↗
Gravett David M.	VP, Research & Development	A Award deriv	2015-08-03	2015-08-05	47,006	—	$0	47,006	SEC↗
Zadno Reza	Director	A Award deriv	2015-04-24	2015-04-27	6,250	—	$0	6,250	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	387,960	—	$0	0	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	304,438	—	$0	0	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	2,230	—	$0	0	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	2,476,452	—	$0	0	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	2,842	—	$0	0	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	18,142	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-14	2,842	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-14	304,438	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-14	387,960	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-14	2,476,452	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-14	18,142	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-14	2,230	—	$0	0	SEC↗
NOHRA GUY P	Director	C Conversion deriv	2015-04-14	2015-04-14	424,346	—	$0	0	SEC↗
NOHRA GUY P	Director	C Conversion deriv	2015-04-14	2015-04-14	727,590	—	$0	0	SEC↗
NOHRA GUY P	Director	C Conversion deriv	2015-04-14	2015-04-14	332,990	—	$0	0	SEC↗
NOHRA GUY P	Director	C Conversion deriv	2015-04-14	2015-04-14	1,981,124	—	$0	0	SEC↗
ACP IV, L.P.	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	332,990	—	$0	0	SEC↗
ACP IV, L.P.	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	727,590	—	$0	0	SEC↗
ACP IV, L.P.	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	1,981,124	—	$0	0	SEC↗
ACP IV, L.P.	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	424,346	—	$0	0	SEC↗
InterWest Partners IX, LP	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	466,357	—	$0	0	SEC↗
InterWest Partners IX, LP	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	365,957	—	$0	0	SEC↗
InterWest Partners IX, LP	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	2,145,351	—	$0	0	SEC↗
InterWest Partners IX, LP	10% Owner	C Conversion deriv	2015-04-14	2015-04-14	831,531	—	$0	0	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion deriv	2015-04-14	2015-04-24	2,476,452	—	$0	0	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion deriv	2015-04-14	2015-04-24	2,230	—	$0	0	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion deriv	2015-04-14	2015-04-24	18,140	—	$0	0	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion deriv	2015-04-14	2015-04-24	2,842	—	$0	0	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion deriv	2015-04-14	2015-04-24	387,960	—	$0	0	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion deriv	2015-04-14	2015-04-24	304,438	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-27	387,960	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-27	304,438	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-27	2,842	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-27	2,476,452	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-27	2,230	—	$0	0	SEC↗
CHA ALBERT	Director	C Conversion deriv	2015-04-14	2015-04-27	18,140	—	$0	0	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion	2015-04-14	2015-04-14	2,476,452	—	$0	2,476,452	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion	2015-04-14	2015-04-14	2,842	—	$0	2,885,396	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion	2015-04-14	2015-04-14	304,438	—	$0	3,189,834	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion	2015-04-14	2015-04-14	2,230	—	$0	3,192,064	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion	2015-04-14	2015-04-14	387,960	—	$0	2,882,554	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	C Conversion	2015-04-14	2015-04-14	18,142	—	$0	2,494,594	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	P Buy	2015-04-14	2015-04-14	7,364	$5.00	$36.8K	4,204,564	SEC↗
VIVO VENTURES VI AFFIILATES FU	10% Owner	P Buy	2015-04-14	2015-04-14	1,005,136	$5.00	$5.03M	4,197,200	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-14	2,230	—	$0	3,192,064	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-14	304,438	—	$0	3,189,834	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-14	2,842	—	$0	2,885,396	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-14	387,960	—	$0	2,882,554	SEC↗
CHA ALBERT	Director	P Buy	2015-04-14	2015-04-14	1,005,136	$5.00	$5.03M	4,197,200	SEC↗
CHA ALBERT	Director	P Buy	2015-04-14	2015-04-14	7,364	$5.00	$36.8K	4,204,564	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-14	18,142	—	$0	2,494,594	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-14	2,476,452	—	$0	2,476,452	SEC↗
NOHRA GUY P	Director	C Conversion	2015-04-14	2015-04-14	332,990	—	$0	3,466,050	SEC↗
NOHRA GUY P	Director	C Conversion	2015-04-14	2015-04-14	424,346	—	$0	3,133,060	SEC↗
NOHRA GUY P	Director	C Conversion	2015-04-14	2015-04-14	1,981,124	—	$0	2,708,714	SEC↗
NOHRA GUY P	Director	C Conversion	2015-04-14	2015-04-14	727,590	—	$0	727,590	SEC↗
NOHRA GUY P	Director	P Buy	2015-04-14	2015-04-14	877,500	$5.00	$4.39M	4,343,550	SEC↗
ACP IV, L.P.	10% Owner	C Conversion	2015-04-14	2015-04-14	424,346	—	$0	3,133,060	SEC↗
ACP IV, L.P.	10% Owner	C Conversion	2015-04-14	2015-04-14	1,981,124	—	$0	2,708,714	SEC↗
ACP IV, L.P.	10% Owner	C Conversion	2015-04-14	2015-04-14	727,590	—	$0	727,590	SEC↗
ACP IV, L.P.	10% Owner	P Buy	2015-04-14	2015-04-14	877,500	$5.00	$4.39M	4,343,550	SEC↗
ACP IV, L.P.	10% Owner	C Conversion	2015-04-14	2015-04-14	332,990	—	$0	3,466,050	SEC↗
InterWest Partners IX, LP	10% Owner	P Buy	2015-04-14	2015-04-14	810,000	$5.00	$4.05M	4,619,196	SEC↗
InterWest Partners IX, LP	10% Owner	C Conversion	2015-04-14	2015-04-14	365,957	—	$0	3,809,196	SEC↗
InterWest Partners IX, LP	10% Owner	C Conversion	2015-04-14	2015-04-14	466,357	—	$0	3,443,239	SEC↗
InterWest Partners IX, LP	10% Owner	C Conversion	2015-04-14	2015-04-14	2,145,351	—	$0	2,976,882	SEC↗
InterWest Partners IX, LP	10% Owner	C Conversion	2015-04-14	2015-04-14	831,531	—	$0	831,531	SEC↗
Vivo Ventures VI, LLC	10% Owner	P Buy	2015-04-14	2015-04-24	1,005,136	$5.00	$5.03M	4,197,198	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion	2015-04-14	2015-04-24	2,230	—	$0	3,192,062	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion	2015-04-14	2015-04-24	304,438	—	$0	3,189,832	SEC↗
Vivo Ventures VI, LLC	10% Owner	P Buy	2015-04-14	2015-04-24	7,364	$5.00	$36.8K	4,204,562	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion	2015-04-14	2015-04-24	387,960	—	$0	2,882,552	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion	2015-04-14	2015-04-24	18,140	—	$0	2,494,592	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion	2015-04-14	2015-04-24	2,476,452	—	$0	2,476,452	SEC↗
Vivo Ventures VI, LLC	10% Owner	C Conversion	2015-04-14	2015-04-24	2,842	—	$0	2,885,394	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-27	304,438	—	$0	3,189,832	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-27	2,842	—	$0	2,885,394	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-27	387,960	—	$0	2,882,552	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-27	18,140	—	$0	2,494,592	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-27	2,230	—	$0	3,192,062	SEC↗
CHA ALBERT	Director	P Buy	2015-04-14	2015-04-27	1,005,136	$5.00	$5.03M	4,197,198	SEC↗
CHA ALBERT	Director	P Buy	2015-04-14	2015-04-27	7,364	$5.00	$36.8K	4,204,562	SEC↗
CHA ALBERT	Director	C Conversion	2015-04-14	2015-04-27	2,476,452	—	$0	2,476,452	SEC↗